RT Journal Article
SR Electronic
T1 Rosiglitazone disrupts pancreatic ductal adenocarcinoma progression by activating the tumor suppressor ESE3/EHF
JF Cancer Biology & Medicine
JO Cancer Biology & Medicine
FD China Anti-Cancer Association
SP 945
OP 947
DO 10.20892/j.issn.2095-3941.2022.0299
VO 19
IS 7
A1 Hongquan Wang
A1 Shuang Wu
A1 Yan Wang
A1 Bo Tang
YR 2022
UL http://www.cancerbiomed.org/content/19/7/945.abstract
AB